Hospital-At-Home Continuous Vital-Sign Patches
Adhesive body-worn patches that automatically and continuously capture multi-parameter vital signs in acutely ill patients being treated at home, enabling hospital-level deterioration surveillance outside the ward without repeated manual observations by patients or carers.
Developed mainly in: United KingdomImpacting: North America, Europe and Australia
Researchers at the Universities of Oxford and Warwick, with NIHR Oxford BRC support, trialled adhesive chest patches on 26 acutely unwell adults under Oxford University Hospitals' Hospital at Home service. Published in JMIR Formative Research, the study found continuous passive vital-sign capture workable for infections, heart failure and similar conditions, easing the burden on frail patients and…
This is one of 24 signals scored in our latest scan.
Track Them Free For 14 Days →Since we flagged this
First flagged
13 October 2026 · score 5.0/10
Corroborating sources since flagging
7
Latest signals
Tracked from 2 signals, each traced to its source.
- Oxford feasibility trial tests chest-worn patches for monitoring acutely ill home patients
Oxfordbrc · 15 Oct 2026
- Oxford feasibility study monitors acutely ill home patients with wearable chest patches
Ouh · 13 Oct 2026
In the full record
Evolution
Score over time, Score Jumps and how the evidence built up since the first signal.
Thesis
Paradigm Shift, Commercial Viability, signal strength and the driver of the change.
Why this innovation matters
The full analysis: what is shifting, who is affected and the second-order effects.
Forecasted Hypothesis
What would strengthen this innovation, and what would weaken it.
Exposure
Companies and publicly listed stock symbols linked to this innovation.
Every signal
Each signal with its date, score, flags and original source.
Open the full record free for 14 days → No card needed.
More in Healthcare
Other innovations the engine is currently tracking in this industry.
- Image-Based Cancer Prognostic Modelling6.5/ 10 · 2 signals
- Automated Quantitative Imaging Biomarkers5.5/ 10 · 2 signals
- Prescription Digital Therapeutics7.0/ 10 · 10 signals
- Oral Small-Molecule GLP-1 Agonists7.8/ 10 · 6 signals
- At-Home Prescription Neuromodulation6.5/ 10 · 2 signals
- Clinical-Grade Wearable Biosensing6.0/ 10 · 2 signals
Track every innovation, free for 14 days
Full Analyst access from the first day. No card. Then subscribe to keep it.
- The radar: every innovation, ranked by Disruption Score
- Tracked evolution: score over time, Score Jumps and how the evidence built up
- Thesis and analysis: Commercial Viability, Paradigm Shift, why it matters, what would change it
- Geography: where each innovation is developed and where it has impact
- Exposure: the companies and public stock symbols behind each innovation
- Every signal with its source, and what moved since your last visit
- Email alerts when an innovation moves: First Signal, Score Jump and briefings
Disclaimer: The information provided on this page is for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Stock data shown is illustrative and may not reflect real-time prices. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.